Emerging markets are developmental states. Crucially, however, they have become major players in the global economy. It is perhaps a fitting analogy for the MSc student. We seek to transform the potential of graduates, building on existing knowledge and qualifications to create a powerful, personal blend of practical knowledge and intuitive insight.
Why choose the MSc in International Business & Emerging Markets?Our students provide an insight into the IBEM programme and share why they enjoyed it »
The MSc in International Business and Emerging Markets will help students understand how to conduct a business internationally and how to do so from developmental states. Students will be able understand the particular challenges faced in developing corporate strategy, attracting foreign direct investment and working in countries with very different cultures, institutions, laws and business practices.
In their first term (Sep-Dec) students will take induction and core course, while choosing optional courses in their second term (Jan-May). The final dissertation is written over the summer term (Jun-Aug). Our courses have an overarching aim to inform students how businesses can take advantage of the globalisation of economy and to understand the rapid development of these new economic powerhouses.
The success of our MSc in International Business and Emerging Markets is reflected in the career destinations of our graduates. Students come from all over the world, looking for objective, in-depth insights into global business practice. The knowledge they gather helps them develop successful careers as consultants, managers or analysts in the broad arena of international business.
A strong academic base, passionate faculty and international cohort will ensure a rewarding student experience in our city-centre campus. The School has widespread industry links and students will have exposure to a range of guest speakers. These speakers have represented a number of businesses including Accenture, AEGON, Egon Zehnder International, Roche Group, Royal Bank of Scotland, Shell and Tesco.